A second polymorphism identified by a fragment co-amplified with c-Ki-ras.
Heighway
J
J
Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester, UK.
D002881:Chromosomes, Human, Pair 12; D004273:DNA, Neoplasm / Q000235:genetics; D015252:Deoxyribonucleases, Type II Site-Specific; D005784:Gene Amplification; D005787:Gene Frequency; D006801:Humans; D012150:Polymorphism, Restriction Fragment Length; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras)
D004273:DNA, Neoplasm; D011518:Proto-Oncogene Proteins; C047564:CCANNNNNNTGG-specific type II deoxyribonucleases; D015252:Deoxyribonucleases, Type II Site-Specific; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)